KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Total Debt (2016 - 2025)

Cvs Health (CVS) has disclosed Total Debt for 17 consecutive years, with $60.5 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Debt fell 5.69% year-over-year to $60.5 billion, compared with a TTM value of $60.5 billion through Dec 2025, down 5.69%, and an annual FY2025 reading of $60.5 billion, down 5.69% over the prior year.
  • Total Debt was $60.5 billion for Q4 2025 at Cvs Health, down from $61.8 billion in the prior quarter.
  • Across five years, Total Debt topped out at $64.7 billion in Q3 2024 and bottomed at $52.2 billion in Q3 2022.
  • Average Total Debt over 5 years is $59.7 billion, with a median of $61.0 billion recorded in 2023.
  • The sharpest move saw Total Debt decreased 17.19% in 2021, then rose 18.58% in 2023.
  • Year by year, Total Debt stood at $56.2 billion in 2021, then dropped by 6.98% to $52.3 billion in 2022, then grew by 17.52% to $61.4 billion in 2023, then grew by 4.46% to $64.2 billion in 2024, then fell by 5.69% to $60.5 billion in 2025.
  • Business Quant data shows Total Debt for CVS at $60.5 billion in Q4 2025, $61.8 billion in Q3 2025, and $63.4 billion in Q2 2025.